Teva Faces Infringement Suits Over TriCor Patent

By Ron Zapata · March 3, 2008, 12:00 AM EST

Brussels-based drug manufacturer Solvay Pharmaceuticals has filed patent infringement lawsuits to stop Teva Pharmaceuticals from selling a generic version of cholesterol drug TriCor – a move that will likely prompt additional...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Ron

February 09, 2009
Life Sciences Practice: Reed Smith
June 26, 2008
Exxon Ruling Will Drill Punitive Awards: Experts
June 23, 2008
Judge Closes Merck Derivative Suit Over Vioxx
June 16, 2008
Fed. Circuit Boots Fee Award Back To Lower Court
June 03, 2008
Cephalon Sues Watson To Block Generic Fentora
June 02, 2008
Misconduct Testimony Allowed In Pfizer Age Bias Suit
June 02, 2008
No IP Info For Protonix Antitrust Plaintiffs: Judge
May 30, 2008
Vioxx Deal Holds Up Even After Appeals Wins: Experts
May 29, 2008
Two Courts Overturn Vioxx Rulings Against Merck
May 28, 2008
Australian Court Upholds Pfizer's Lipitor Patent